The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to ...

What To Know: Under the agreement, all strengths of the medications will now be available to eligible self-paying patients at $499 per month through GoodRx's platform.

When Opill became available a year ago, public health experts anticipated it would benefit women without health insurance and those residing in rural areas. The goal was to boost access to ...

Weight loss before pregnancy linked to lower rates of gestational diabetes and C-sections. Experts discuss implications, limitations, and how to counsel patients.

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some ...

The Little Mix singer said she auditioned for "The X Factor" just months after leaving the hospital, where she was treated ...

According to NPR, doctors and patients alike have noted the drug has appeared to reduce some people's cravings for booze, ...

Californians who get their health insurance through the state’s marketplace will see premiums increase by an average of 10.3% ...

Presenter and actress Rosie O'Donnell is the latest celeb to show off the results of taking Mounjaro for her diabetes ...

GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.